Investment Stage

Focus Areas

About Investor

Christoph Broja is a Partner in the EQT Life Sciences team, where he helps lead investments in innovative life-science companies. He focuses on biotech, pharmaceuticals, medical devices and molecular diagnostics, backing companies at a range of stages with typical investments between $11.0M and $65.0M. Previously he was a Principal and Senior Associate at Gurnet Point Capital, worked at B-Flexion Capital in London, and started his career as an investment analyst at Franz Haniel & Cie. Broja holds a degree in Business Administration and is a CFA charterholder, reflecting a strong finance and analytical background applied to life-sciences investing.